- stock
- bulk
- Price
Supplier Type
- Manufacturer
- Trader
- Reagent
- custom synthesis
- contract manufacturer
Supplier Region
- Hyderabad(31)
- Gujarat(24)
- Andhra Pradesh(4)
- Bangalore(1)
- Mumbai(18)
- Telangana(1)
- Maharashtra(12)
- Delhi(2)
- Karnataka(4)
- Ahmedabad(5)
- Uttar Pradesh(2)
- Pune(2)
- New Delhi(1)
- Tamil Nadu(1)
- Kolkata(1)
- Haryana(2)
- Vadodara(1)
Purity
- VETRANAL?, analytical standard
- United States Pharmacopeia (USP) Reference Standard
- thyroid hormone analog
- technical grade, 90%
- tech. Viscosity 15-40 mPa.s (20 °C)
- solid
- ReagentPlus?, 99%
- powder
- phyproof? Reference Substance
- pharmaceutical secondary standard, certified reference material
- Pharmaceutical Secondary Standard
- Novabiochem?
- NLT 99%
- NLT 95%
- more than 90%
- lyophilized powder
- InSolution ≥95%
- HPLC)
- Greater than 99%
- GC)
- for synthesis
- European Pharmacopoeia (EP) Reference Standard
- configured for MerMade
- configured for ABI
- configured for (?KTA? and OligoPilot?)
- Chemically Pure
- certified reference material, pharmaceutical secondary standard
- Certified Reference Material
- Carboxylate form of Lovastatin that is active in whole cells and cell-free assays.
- British Pharmacopoeia (BP) Reference Standard
- b-[10-(1-naphthalenyl)-9-anthracenyl]- 97%
- Avanti Polar Lipids
- analytical standard
- AldrichCPR
- ABOVE 99%
- 99.9%
- >99.0%(T)
- >99.0%(GC)
- ≥99.0% (T)
- 99%+
- >99%
- ≥99%
- 99%
- 98+
- >98.0%(T)(N)
- >98.0%(T)(HPLC)
- >98.0%(T)
- >98.0%(N)
- >98.0%(HPLC)(N)
- >98.0%(HPLC)
- >98.0%(GC)(T)
- >98.0%(GC)(N)
- >98.0%(GC)
- ≥98.0% (CHN)
- 98% Min
- ≥98% (TLC)
- ≥98% (HPLC)
- 98%
- ≥98%
- >98%
- 97-99 %
- >97.0%(T)(N)
- >97.0%(T)(HPLC)
- >97.0%(T)
- >97.0%(N)
- >97.0%(HPLC)(N)
- >97.0%(HPLC)
- >97.0%(GC)(T)
- >97.0%(GC)
- ≥97.0% (T)
- 97.0%
- ≥97%
- 97%
- >97%
- >96.0%(T)(HPLC)
- >96.0%(T)
- >96.0%(HPLC)(N)
- >96.0%(HPLC)
- >96.0%(GC)(T)
- >96.0%(GC)
- ≥96.0% (GC)
- 96%
- >96%
- >95.0%(T)
- >95.0%(HPLC)
- >95.0%(GC)(T)
- >95.0%(GC)
- 95%+
- ≥95% (HPLC)
- 95% (HPLC)
- >95%
- 95%
- >94.0%(GC)
- 92%
- 92
- ≥90% (HPLC)
- 4-[(2r)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)- 95%
- 1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine, powder
- 1,1-dimethylethyl ester 95%
- &ge
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 1mg
- IND837-1G
- 5μg
- 10μg
- 50μg
- 100μg
- 0.18
- 8523530005
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 5mg
- 10mg
- 15mg
- 20mg
- 25mg
- 50mg
- 100mg
- 125mg
- 150mg
- 200MG
- 250mg
- 350mg
- 500MG
- 1000mg
- 1gm
- 1mL
- 1g
- 2g
- 5mL
- 5g
- 5gm
- 10gm
- 10g
- 25gm
- 25g
- 25mL
- 50g
- 100g
- 100gm
- 100mL
- 250ML
- 250gm
- 250G
- 500g
- 500gm
- 500mL
- 1kg
- 10EACH
- 5kg
- 10kg
- 25kg
- 36kg
- 37kg
- 40kg
- 50kg
- 58kg
- 99kg
- 100kg
- 180kg
- 250kg
- 500kg
- 1Gms
- 1MT
- 5Gms
- 18%
- 25Gms
- 100Gms
- 100μL
- 200Kg drum
Simvastatin Impurity-D/Simvastatin USP Related Compound D / Simvastatin Dimer 476305-24-5
R-2-BENZYLOXY PROPIONIC ACID 100836-85-9
4-Chloro-7-tosy1-7Hpyrrolo[2,3-d]pyrimidine 479633-63-1
8-Bromo-3-methyl xanthine 93703-24-3
Dihydrofuran-3(2H)-one 22929-52-8
N-Boc 4-piperdine methanol 123855-51-6
2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid 851784-82-2
N-(2-chloropyrimidin-4-yl)-2,3- dimethyl- 2H-indazol-6- amine 444731-74-2











